China’s Ally Bridge Group hit the investment world’s radar in 2015 with its audacious move to take CRO WuXi PharmaTech Inc. private. If the firm and its partners can engineer the first…
By Hui Cai, VP of Corporate Alliances at WuXi AppTec (@HuiCai2) As the globalization of healthcare expands, Frank Yu and his team at Ally Bridge Group continue to differentiate themselves in…
Frank Yu, founder of healthcare-focused investment firm Ally Bridge Group and formerly head of China Investments at Och-Ziff Capital Management, answers five questions in this video interview with Nina Xiang,…
Hong Kong-based Ally Bridge Group took a hand in a $155 million placement in immuno-oncology biotech Tesaro ($TSRO), joining a funding round led by Kleiner Perkins along with New Enterprise…
